Biotech Lessons Learned from the Genentech and Roche QbD Journey

• Does QbD need a makeover? • Summary of lessons learned including recent successes & challenges with enhanced QbD submissions to FDA. • From Genentech/Roche’s experience implementation of QbD in regulatory submissions is evolving as evidence by current examples of categorization of CPPs/CQAs and effective design space descriptions.